Industry: Pharmaceuticals, Biotechnology
Rexahn (OTCBB: RXHN) is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, disorders of the central nervous system, and unmet medical needs. Our research and development focus in oncology is on signal transduction inhibitors, which directly target the communication system of cancer cells. Our oncology candidates block specific signals that lead to cell proliferation and the growth of cancerous tumors. Disorders of the central nervous system are our research and development focus in the area of neuroscience. In behavioral and biochemical models, our lead neuroscience candidate has demonstrated significant activity against anxiety and ( www.rexahn.com )
Rexahn Pharmaceuticals, Inc.
9620 Medical Center Drive
Rockville, Maryland 20850
USA
Tel: (240) 268-5300
Fax: (240) 268-5310